Dedicated to putting men back in control of their urinary retention.

Innovative catheters designed for better quality of life

Since 2013, we’ve been developing innovative catheters to improve the quality of life of both patients and health care providers. We specialise in creating innovative, clinically relevant, and cost-effective solutions to problems of urinary flow and control.

CE Mark under MDR Granted for cymactive

2024

International PTC Patent Granted

2022

International PTC Patent Filing

2019

Further Patients Data Gathered Through Studies

2018

Clinical BETA Test of 1st Gen. Device

2014

Ingenion Medical Limited Founded In The UK

2013

Meet the team

Senior Management
Edward Cappabianca
Chief Executive Officer (CEO) & Executive Director
Experienced investment banker who has also served as CEO of two early-stage life science companies. Has raised over US$2 billion in a range of financings from private & public equity to private debt and grant funding.
Zia Mursaleen
Chief Financial Officer (CFO)
Mursaleeen is qualified as a chartered accountant with Deloitte, where he worked for 10 years. Director of Corporate Finance and Finance Director of the Public Houses Division of Ascot Holdings.
Susan Finch
Chief Operating Officer (COO)
Finch spent 7 years as General Manager for Pennine Healthcare, in addition to years of operational management experience in other industries with companies such as Bosch and ICO Polymers. Susan received her MBA from Nottingham University Business school.
Tim Maloney
Commercial Director
Tim has over 15 years experience in the medical device industry, starting with Bard in the US, and subsequently with Biocompatibles, plc, where he served as Business Development Director and Sales Director for two of their largest business units.
Board of Directors
Sergio Rothstein
Chairman
Rothstein was one of the four founders of the original business Urovalve, Inc. and led the subsequent formation of Ingenion Medical Limited.
Barry Clare
Non-Executive Director (NED)
Clare is the former main board director of Boots Company plc and Chairman of Healthcare Brands International and Betapharm. Chairman of Vantage Diagnostics Ltd, Lichwer Pharma AG. and Evgen Pharma Ltd. Chairman of University Hospital of South Manchester Foundation Trust.
Michael Erlich
Non-Executive Director (NED)
An NIJT Associate Professor. Member of the NY Angels and co-directs the New Jersey Innovation Acceleration Centre.
Alan Coldsnow
Non-Executive Director (NED)
Practicing lawyer, admitted to NY and DC bar. Shareholder representative.
Copyright © 2024 - All Rights Reserved
Contact Ingenion Medical to find out if cymactive™️ is approved for sale in your market.